Trulieve Cannabis Corp.
TRLVStock
$10.10+236.11%52W
Market Cap$2.53B
P/E—
Div yield—
Beta1.13
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)99.95%
Price vs S&P 500 (4W)56.34%
VGM Score4.03
Market Capitalization$2.53B
Industry Peers — Pharmaceutical Preparations(19)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
TRLVTrulieve Cannabis Corp. | — | — | F | $10.10 |
| RGCRegencell Bioscience Holdings Limited Ordinary Shares | — | — | D | $12.01 |
| DFTXDefinium Therapeutics, Inc. Common Shares | — | — | A | $24.48 |
| CRONCronos Group Inc. Common Share | C | B | C | $2.71 |
| TLRYTilray Brands, Inc. Common Stock | B | B | D | $4.73 |
| CGCCanopy Growth Corporation Common Shares | B | D | D | $0.97 |
| USNAUSANA Health Sciences Inc | B | D | D | $18.88 |
| NAGENiagen Bioscience, Inc. Common Stock | C | B | F | $3.50 |
| SNDLSundial Growers Inc. Common Shares | A | C | C | $1.42 |
| MDWDMediWound Ltd. | D | F | D | $14.24 |
| ACBAurora Cannabis Inc. Common Shares | B | C | D | $2.93 |
About
Trulieve Cannabis Corp is a vertically integrated cannabis company that grows, produces, and sells cannabis products. It has licenses to operate in Arizona, Colorado, Connecticut, Florida, Georgia, Maryland, Ohio, Pennsylvania, and West Virginia, where it sells medical cannabis products. In addition, the company sells cannabis products for adult use in Arizona, Colorado, Connecticut, Maryland, and Ohio. The firm's operations are substantially located in Florida and, to a lesser extent, in Arizona and Pennsylvania.